# IPC The Hospitalist Company

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ipc-the-hospitalist-company

- Industry: Pharmaceuticals
- Headquarters: Los Angeles, US
- Website: www.hospitalist.com
- Total disclosed funding: $37M
- Latest round: Series D (Oct 21, 2002)
- Investors on record: 4

## About

IPC The Hospitalist Company, Inc. delivers healthcare solutions that enhance hospitalist services and patient outcomes through innovative software, optimizing care coordination and hospital management.IPC The Hospitalist Company, Inc. offers specialized hospitalist services, providing a distinctive approach in the healthcare sector. Headquartered in Los Angeles, US, the company has had 7 total deals. Most recently, IPC was acquired by Granite Growth Health Partners, although the financial details of the deal were not disclosed. The latest funding round, a Trade Sale, amounted to USD 1.60 mn, and TeamsHealth, Inc. was involved as an investor. The company has raised a total of USD 1.60 mn.The company specializes in providing a comprehensive range of healthcare solutions designed to optimize hospitalist services and improve patient outcomes. Their core product offerings include advanced software systems that facilitate real-time data sharing among healthcare providers, enhance patient management, and streamline administrative processes. These tools address significant challenges within the healthcare industry, such as improving care coordination, reducing hospital readmission rates, and enhancing the overall patient experience. Their primary customer base consists of hospitals and healthcare networks across North America and Europe, where these products support a diverse array of end users, including physicians, nursing staff, and administrative personnel. The company's solutions are adaptable and applicable across various geographical markets, including both urban and rural settings.The company generates revenue through a subscription-based model that provides clients with access to its suite of healthcare management software and services. The revenue for the most recent year, 2014, amounted to USD 693.985 mn, with an EBITDA of USD 70.37 mn. Clients typically enter into multi-year partnerships, allowing for predictable revenue streams as they pay for continued access and updates to the software. Transactions accommodate both individual hospitals and larger healthcare systems, structured with tiered pricing plans based on adoption scale and specific client needs. This approach establishes long-term client relationships, ensuring ongoing support and service enhancements critical for high standards in patient care and operational efficiency.The company's future growth strategy focuses on developing new products and enhancing existing software capabilities, although specific product launch details are not disclosed. IPC aims to expand into new geographical regions to broaden its market reach. Recent funding from the Trade Sale will be utilized to support these initiatives, enabling the company to strengthen its market position and refine its service offerings.

## Funding rounds

- Series D, Oct 21, 2002, $16M — Morgenthaler Ventures, CB Health Ventures, Scale Venture Partners, Bessemer Venture Partners
- Series C, Jun 1, 2001, $9.3M — Morgenthaler Ventures, CB Health Ventures, Scale Venture Partners, Bessemer Venture Partners
- Series B, Jun 1, 1999, $13M — Morgenthaler Ventures, CB Health Ventures, Scale Venture Partners, Bessemer Venture Partners
- Series A, Jun 1, 1998 — Morgenthaler Ventures, Bessemer Venture Partners

## Investors

- Morgenthaler Ventures (https://capitalatlas.ai/funds/morgenthaler-ventures) — Series A, Series B, Series C, Series D
- Bessemer Venture Partners (https://capitalatlas.ai/funds/bessemer-venture-partners) — Series A, Series B, Series C, Series D
- CB Health Ventures (https://capitalatlas.ai/funds/cb-health-ventures) — Series B, Series C, Series D
- Scale Venture Partners (https://capitalatlas.ai/funds/scale-venture-partners) — Series B, Series C, Series D
